An ever-growing proportion of patients with acute myocardial infarction undergo coronary thrombolysis; recent estimates indicate that in the United States, about 20% of the annual 700,000 patients with myocardial infarctions receive such therapy.' Even though thrombolysis reduces short-term mortality by approximately 20-30%,2-5 each year a large number of patients leave the hospital with a substantial residual risk of dying. Factors that determine prognosis after myocardial infarction and algorithms for risk stratification have been well established for the prethrombolytic era.6-10 However, it remains to be shown whether these predictors of outcome and risk stratification strategies also apply to the growing proportion of patients who have undergone thrombolysis, and if so, whether high-risk patients selected on the basis of such strategies may benefit from more intense medical or surgical treatment.
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After Myocardial Infarction In patients who do not undergo thrombolysis, many factors related to infarct size and residual left ventricular function have been shown to be major determinants of prognosis.11-13 Residual myocardial ischemia, as determined by angina, recurrent infarction, or abnormal exercise testing, and the presence of multivessel coronary artery disease are other important predictors of outcome.14-16 Finally, in most6"7-20 but not all studies,21,22 frequent or complex ventricular arrhythmias and occurrence of ventricular tachycardia on 24-hour ambulatory ECG recordings also have been shown by multivariate analysis to be independent predictors of death. The role of other factors such as late potentials, heart rate variability, and inducibility of arrhythmias in improving risk stratification after myocardial infarction is not definitely established. Studies using signal-averaged ECGs found that late potentials, which are thought to arise from areas of slow conduction and thus are a possible marker of the substrate for malignant ventricular arrhythmias, were associated with increased mortality.23-26 Decreased heart rate variability, reflecting reduced vagal tone and/or enhanced sympathetic activity, is also associated with a poor prognosis after myocardial infarction,27.8 and in some studies, programmed electrical stimulation has been found useful in predicting the occurrence of arrhythmias or arrhythmic death after myocardial infarction.29,30 Risk stratification based on a combination of such clinical criteria in the prethrombolytic era has been increasingly used in the management of patients with myocardial infarction. It allows identification of patients at low risk who may be followed conservatively and patients at high risk who may benefit from more intense therapy.
Effects of Thrombolysis
Information about predictors of outcome after thrombolysis is rapidly accumulating, and not surprisingly, many of the predictors of mortality established in the prethrombolytic era have been found to retain their value. For 
